Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
Balance Sheet
15 Sheets · Starting from 2023In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 143.00 | 193.00 | 161.00 | 235.00 | 287.00 | 270.00 | 442.00 | 1,083.00 | 1,286.00 | 1,439.00 | 6,068.00 | 5,717.00 | 5,193.00 | 4,734.00 | 4,357.00 | |
|
Current
|
84.00 | 109.00 | 65.00 | 132.00 | 176.00 | 213.00 | 374.00 | 1,007.00 | 1,197.00 | 1,328.00 | 5,865.00 | 5,369.00 | 4,861.00 | 4,236.00 | 3,861.00 | |
| Cash And Equivalents | 47.00 | 40.00 | 32.00 | 94.00 | 141.00 | 187.00 | 340.00 | 973.00 | 1,151.00 | 1,290.00 | 1,861.00 | 2,135.00 | 2,233.00 | 508.00 | 166.00 | |
| Assets | 143.00 | 193.00 | 161.00 | 235.00 | 287.00 | 270.00 | 442.00 | 1,083.00 | 1,286.00 | 1,439.00 | 6,068.00 | 5,717.00 | 5,193.00 | 4,734.00 | 4,357.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | 1.00 | - - | - - | - - | - - | - - | -67.00 | -177.00 | 79.00 | 68.00 | -39.00 | |
| Inventory | 1.00 | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 20.00 | 52.00 | 73.00 | |
| Short Term Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 3,919.00 | 3,026.00 | 2,469.00 | 3,585.00 | 3,517.00 | |
| Other Current Assets | 3.00 | 3.00 | 2.00 | 4.00 | 5.00 | 11.00 | 5.00 | - - | - - | 4.00 | 4.00 | 34.00 | - - | - - | 37.00 | |
|
Non Current
|
59.00 | 84.00 | 95.00 | 102.00 | 110.00 | 56.00 | 68.00 | 76.00 | 88.00 | 110.00 | 202.00 | 348.00 | 331.00 | 497.00 | 495.00 | |
| Property, Plant, Equipment (Net) | 19.00 | 23.00 | 19.00 | 18.00 | 19.00 | 10.00 | 13.00 | 14.00 | 16.00 | 23.00 | 66.00 | 103.00 | 137.00 | 154.00 | 126.00 | |
|
Intangible Assets
|
3.00 | 13.00 | 10.00 | 9.00 | 7.00 | 2.00 | 1.00 | 1.00 | 2.00 | 3.00 | 24.00 | 67.00 | 60.00 | 146.00 | 127.00 | |
| Goodwill | 33.00 | 42.00 | 38.00 | 37.00 | 39.00 | - - | - - | - - | - - | - - | - - | - - | - - | 69.00 | 69.00 | |
| Long Term Investments | - - | - - | - - | 35.00 | - - | 43.00 | 49.00 | 54.00 | 64.00 | 73.00 | 11.00 | 8.00 | 127.00 | 119.00 | 13.00 | |
| Other Non Current Assets | - - | 1.00 | 24.00 | 35.00 | 39.00 | 44.00 | 50.00 | 58.00 | 67.00 | 7.00 | 96.00 | 164.00 | 2.00 | 5.00 | 157.00 | |
| Liabilities | 34.00 | 45.00 | 42.00 | 116.00 | 120.00 | 64.00 | 77.00 | 324.00 | 274.00 | 225.00 | 3,192.00 | 3,047.00 | 2,549.00 | 2,208.00 | 1,561.00 | |
|
Current
|
31.00 | 38.00 | 35.00 | 109.00 | 112.00 | 60.00 | 72.00 | 103.00 | 171.00 | 219.00 | 571.00 | 635.00 | 566.00 | 522.00 | 428.00 | |
| Accounts Payable | - - | - - | - - | - - | 2.00 | - - | - - | - - | - - | - - | 79.00 | 31.00 | -35.00 | -2.00 | 31.00 | |
| Short Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | - - | 2.00 | 5.00 | 6.00 | 7.00 | 7.00 | 4.00 | |
| Deferred Revenue | - - | - - | 1.00 | 83.00 | 78.00 | 27.00 | 39.00 | 70.00 | 122.00 | 149.00 | 414.00 | 443.00 | 419.00 | 365.00 | 256.00 | |
| Tax Payable | - - | - - | - - | - - | - - | 2.00 | 2.00 | 1.00 | - - | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | - - | |
| Other Current Liabilities | 15.00 | 15.00 | 16.00 | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 | 4.00 | - - | 9.00 | 14.00 | 5.00 | 16.00 | 32.00 | |
|
Non Current
|
3.00 | 7.00 | 7.00 | 7.00 | 7.00 | 3.00 | 5.00 | 220.00 | 102.00 | 5.00 | 2,621.00 | 2,412.00 | 1,983.00 | 1,685.00 | 1,133.00 | |
| Long Term Debt | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 19.00 | 23.00 | 19.00 | 14.00 | 4.00 | |
| Leasing Obligations | 1.00 | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | 25.00 | 29.00 | 26.00 | 21.00 | 9.00 | |
| Deferred Non Current Tax Liabilities | - - | 2.00 | 2.00 | 2.00 | 2.00 | - - | - - | 3.00 | - - | - - | 8.00 | 14.00 | 11.00 | 20.00 | 23.00 | |
| Other Non Current Liabilities | 1.00 | 3.00 | 4.00 | 5.00 | 5.00 | 3.00 | 5.00 | 6.00 | 5.00 | 5.00 | 6.00 | 8.00 | 7.00 | 27.00 | 33.00 | |
| Equity | 108.00 | 148.00 | 118.00 | 118.00 | 167.00 | 206.00 | 364.00 | 758.00 | 1,011.00 | 1,214.00 | 2,875.00 | 2,670.00 | 2,643.00 | 2,526.00 | 2,795.00 | |
| Stockholders' Equity | 108.00 | 148.00 | 118.00 | 118.00 | 167.00 | 206.00 | 364.00 | 758.00 | 1,011.00 | 1,214.00 | 2,875.00 | 2,670.00 | 2,643.00 | 2,526.00 | 2,795.00 | |
| Retained Earnings | -66.00 | -60.00 | -91.00 | -94.00 | -100.00 | -63.00 | -177.00 | -112.00 | -211.00 | -297.00 | -109.00 | -334.00 | -367.00 | -496.00 | -228.00 | |
| Common Stock | 122.00 | 137.00 | 137.00 | 139.00 | 154.00 | 157.00 | 185.00 | 223.00 | 233.00 | 236.00 | 287.00 | 291.00 | 292.00 | 293.00 | 293.00 | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | 3.00 | 4.00 | -33.00 | -5.00 | -8.00 | 33.00 | -118.00 | 54.00 | -115.00 | -29.00 | 149.00 | -305.00 | -103.00 | -217.00 | 211.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | - - | - - | 72.00 | 112.00 | 114.00 | 357.00 | 649.00 | 993.00 | 1,277.00 | 2,703.00 | 2,727.00 | 2,730.00 | 2,735.00 | 2,736.00 | |
| Loss Other Compr. Income | 52.00 | 71.00 | 72.00 | - - | - - | -1.00 | - - | -2.00 | -3.00 | -2.00 | -5.00 | -14.00 | -11.00 | -6.00 | -7.00 |